Meeting Public Comments

Subcommittee meeting and times are as follows:
Attendance at subcommittee meetings by lobbyists and the public is via zoom or in-person. See agenda for zoom details. Only authenticated users are permitted access.
A bill for an act relating to the administration of medical cannabidiol by educational institutions and long-term care facilities.
Subcommittee members: Zaun-CH, Bolkcom, Sinclair
Date: Wednesday, February 9, 2022
Time: 2:30 PM - 3:00 PM
Location: Room G15
Comments Submitted:
The purpose of comments is to provide information to members of the subcommittee.
Names and comments are public records. Remaining information is considered a confidential record.

Carl Olsen []
2020 Acts Chapter 1116 (HF 2589), Sec. 31: PROTECTION OF FEDERAL FUNDING. The department of public health shall request guarantees from the agencies of the federal government providing funding to educational and longterm care facilities that facilities with policies allowing patients to possess medical cannabidiol on the grounds of the facilities consistent with chapter 124E or allowing facility staff to administer medical cannabidiol to a patient shall not lose eligibility for any federal funding due to such policies. On April 23, 2021, the department sent this request to the U.S. Drug EnforcementAdministration. On February 8, 2022, the Senate Judiciary Committee approved SCR 101, which would request a response from the U.S. Drug Enforcement Administration to the departments request on April 23, 2021. SSB 3112 would authorize facility staff to administer medical cannabidiol, consistent with 2020 Acts Chapter 1116, Sec. 31, and SCR 101 (2022). Please support SSB 311. Thank you!
Carl Olsen []
The Zoom feed cut out around 2:45 p.m., but it might be a good idea to issue a registration to each person in a facility that will administer medical cannabidiol to a registered patient. This will really ease the burden on caregivers who have to visit the facility and remove the registered patient to administer the medical cannabidiol. The issue of federal drug law is being addressed in Senate Concurrent Resolution 101, so all these pieces will work together to greatly improve the program. A federal exemption would reduce the cost tremendously, just because of the federal tax penalty currently being applied due to 26 U.S.C. 280E.